NFGH
ABCL icon

Nan Fung Group Holdings’s AbCellera Biologics ABCL Stock Holding History

Nan Fung Group Holdings’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-50,971
Closed -$151K – 39
2024
Q2 		$151K Hold
50,971
– – 0.16% 40
2024
Q1 		$231K Buy
50,971
+38,450
+307% +$196K 0.21% 39
2023
Q4 		$71.5K Hold
12,521
– – 0.04% 36
2023
Q3 		$57.6K Hold
12,521
– – 0.05% 36
2023
Q2 		$80.9K Hold
12,521
– – 0.05% 41
2023
Q1 		$94.4K Hold
12,521
– – 0.06% 42
2022
Q4 		$127K Hold
12,521
– – 0.09% 38
2022
Q3 		$124K Hold
12,521
– – 0.08% 36
2022
Q2 		$133K Hold
12,521
– – 0.09% 37
2022
Q1 		$122K Sell
12,521
-659
-5% -$6.24K 0.06% 41
2021
Q4 		$188K Buy
+13,180
New +$200K 0.06% 49

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return